Context Therapeutics Common Stock Net 2021-2025 | CNTX

Context Therapeutics common stock net from 2021 to 2025. Common stock net can be defined as the value of common equity ownership.

Context Therapeutics Common Stock Net 2021-2025 | CNTX

Context Therapeutics common stock net from 2021 to 2025. Common stock net can be defined as the value of common equity ownership.
Related Stocks
Company NameMarket
Cap
Chugai Pharmaceutical (CHGCY)$69.6B
Zoetis (ZTS)$67.5B
Daiichi Sankyo, - (DSNKY)$48.8B
Takeda Pharmaceutical (TAK)$48.2B
BeOne Medicines - (ONC)$35B
Sandoz Group AG (SDZNY)$26.3B
Summit Therapeutics (SMMT)$19.5B
Merck (MKKGY)$16.7B
Shionogi (SGIOY)$14.9B
United Therapeutics (UTHR)$14.2B
Neurocrine Biosciences (NBIX)$13.2B
Orion OYJ (ORINY)$11.2B
IPSEN (IPSEY)$10.6B
Eisai (ESAIY)$9.2B
Madrigal Pharmaceuticals (MDGL)$8.7B
Corcept Therapeutics (CORT)$7.6B
Grifols, S.A (GRFS)$7.3B
Ionis Pharmaceuticals (IONS)$6.9B
Stevanato Group S.p.A (STVN)$6.8B
Hikma Pharmaceuticals Plc (HKMPF)$5.4B
Ono Pharmaceutical (OPHLF)$5.4B
Soleno Therapeutics (SLNO)$3.6B
AMNEAL PHARMACEUTICALS, INC (AMRX)$2.9B
NewAmsterdam Pharma (NAMS)$2.9B
Crinetics Pharmaceuticals (CRNX)$2.8B
Hypermarcas (HYPMY)$2.6B
Catalyst Pharmaceuticals (CPRX)$2.5B
Centessa Pharmaceuticals (CNTA)$2.4B
Ocular Therapeutix (OCUL)$2.1B
Endo (NDOI)$1.8B